Biotherapeutic Analysis

Monoclonal antibodies (mAbs) are among the fastest-growing therapeutics. They are being developed for a broad range of indications, from cancer to infectious diseases to high cholesterol. Antibody Drug Conjugates (ADCs) are mAbs attached to biologically active drugs by chemical linkers. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. Sigma-Adrich has a wide variety of solutions for the characterization and analysis of these biotherapeutics. Reagents, standards, and columns can all be found below. Additionally, we offer custom manufacturing solutions and cell line development through SAFC.